Application 125509
- Type
- BLA
- Sponsor
- ELUSYS THERAPEUTICS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ANTHIM | OBILTOXAXIMAB | INJECTABLE;INJECTION | 600MG/6ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | BLA | Current |
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | BLA | Current |
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | BLA | Current |
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | BLA | Current |
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | BLA | Current |